Nalaganje...
Salvage therapy for hepatocellular carcinoma with thalidomide
AIM: To evaluate the clinical benefit of thalidomide in patients with advanced hepatocellular carcinoma (hepatoma). METHODS: From March 2000 to July 2002, patients who had advanced hepatocellular carcinoma and failed to or were unsuited for aggressive treatment, were enrolled and took thalidomide 15...
Shranjeno v:
| izdano v: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2004
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716902/ https://ncbi.nlm.nih.gov/pubmed/14991931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v10.i5.649 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|